Few literatures have investigated that E2F1 promoted stem cell characteristics and drove malignant progression in glioblastoma through transcriptional regulation [61], which has also been associated with tumor stemness, chemotherapy resistance, and patient prognosis by regulating autophagy through LC3, ATG1, and DRAM [20, 57]. The gene discussed is MAP1LC3A; the disease is neoplasm.